IRIS
LOPALCO, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.398
AS - Asia 3.256
EU - Europa 2.295
SA - Sud America 818
AF - Africa 124
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 3
Totale 14.902
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.258
SG - Singapore 1.539
BR - Brasile 715
CN - Cina 702
HK - Hong Kong 445
SE - Svezia 443
RU - Federazione Russa 424
IT - Italia 366
FR - Francia 270
DE - Germania 241
VN - Vietnam 218
GB - Regno Unito 180
FI - Finlandia 131
CA - Canada 72
IN - India 70
MX - Messico 50
ID - Indonesia 49
CI - Costa d'Avorio 48
AR - Argentina 45
JP - Giappone 40
BD - Bangladesh 37
ZA - Sudafrica 37
ES - Italia 34
IQ - Iraq 34
BE - Belgio 32
PL - Polonia 26
TR - Turchia 26
AT - Austria 23
CZ - Repubblica Ceca 21
NL - Olanda 19
UA - Ucraina 19
LT - Lituania 18
EC - Ecuador 17
PK - Pakistan 15
IE - Irlanda 14
UZ - Uzbekistan 12
IR - Iran 10
PY - Paraguay 10
VE - Venezuela 10
MA - Marocco 9
CO - Colombia 8
KE - Kenya 8
EU - Europa 7
SA - Arabia Saudita 7
AM - Armenia 6
JO - Giordania 6
NP - Nepal 6
HR - Croazia 5
KZ - Kazakistan 5
CH - Svizzera 4
DO - Repubblica Dominicana 4
EG - Egitto 4
KG - Kirghizistan 4
NI - Nicaragua 4
PE - Perù 4
PH - Filippine 4
TN - Tunisia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BB - Barbados 3
CL - Cile 3
DZ - Algeria 3
QA - Qatar 3
RO - Romania 3
SN - Senegal 3
AU - Australia 2
CR - Costa Rica 2
DK - Danimarca 2
GE - Georgia 2
HN - Honduras 2
IL - Israele 2
LU - Lussemburgo 2
ML - Mali 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
GH - Ghana 1
GI - Gibilterra 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
MW - Malawi 1
Totale 14.892
Salva come PNG Salva come JPEG
Città #
Fairfield 1.068
Ashburn 954
Singapore 807
Woodbridge 692
Houston 653
Chandler 574
Seattle 445
Hong Kong 441
Ann Arbor 390
Cambridge 387
Nyköping 364
Wilmington 329
Beijing 296
Dallas 203
Los Angeles 146
New York 138
Lawrence 125
Roxbury 120
Munich 112
Bari 106
Jacksonville 85
Des Moines 78
Nanjing 77
Ho Chi Minh City 72
São Paulo 71
Buffalo 70
Moscow 65
Inglewood 64
Princeton 57
Santa Clara 55
Brooklyn 52
Abidjan 48
London 47
San Diego 45
Turku 42
Helsinki 37
Hanoi 36
Paris 35
Shenyang 35
Jakarta 34
Tokyo 34
Chicago 33
Brussels 32
Johannesburg 29
Dearborn 28
Belo Horizonte 25
Denver 24
Boston 23
Dong Ket 23
Milan 23
Warsaw 23
Montreal 22
Rio de Janeiro 22
San Francisco 22
Toronto 22
Council Bluffs 21
Nanchang 20
Phoenix 20
Mexico City 19
Poplar 19
Brasília 18
The Dalles 18
Atlanta 17
Columbus 17
Frankfurt am Main 17
Chennai 16
Jiaxing 16
Manchester 16
Pune 16
Stockholm 16
Redwood City 15
San Jose 15
Boardman 14
Dublin 14
Orem 14
Tianjin 14
Changsha 13
Guangzhou 13
Hebei 13
Falkenstein 12
Campinas 11
Da Nang 11
San Mateo 11
Tashkent 11
Vienna 11
Augusta 10
Baghdad 10
Brno 10
Dhaka 10
Goiânia 10
Nuremberg 10
Salt Lake City 10
Shanghai 10
Curitiba 9
Giovinazzo 9
Taranto 9
Chaozhou 8
Charlotte 8
Dongguan 8
Guarulhos 8
Totale 10.437
Salva come PNG Salva come JPEG
Nome #
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection 184
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 175
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 167
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 167
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 167
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 160
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study 156
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 156
Retinal vessels thrombosis as onset manifestation of systemic sclerosis: 3 clinical cases 155
A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapy 155
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 155
Basic characteristics of adults with periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome in comparison with the typical pediatric expression of disease 152
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 146
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 145
Refractory knee giant cell tumor of the synovial membrane treated with intra-articular injection of Infliximab: A case series and review of the literature 141
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 141
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis 140
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: Premises, perils, and perspectives 140
AB0369 Adult-onset still’s disease treatment predictors at 1-year follow-up in a single rheumatologic centre experience 140
Different switching rate of anti-TNF-α drugs in monotherapy and in combination with methotrexate in a cohort of rheumatoid arthritis patients in the real life 139
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 138
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 137
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 137
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 136
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 134
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 134
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 134
Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab 132
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 129
Serum amyloid-A in Behçet's disease 128
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 127
SAT0212 Pericardial Effusion Related To Systemic Sclerosis: A Possible Contribution of The Serum Levels of Adipokines and Interleukines 126
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 126
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis 125
Management of Small Vessel Vasculitides 124
Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate 123
Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa 123
Untangling the web of systemic autoinflammatory diseases 121
FRI0110 Methotrexate monotherapy in real life: a drug survival analysis. comparison between very early arthritis and early arthritis cohorts 121
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 119
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study. 116
Longterm clinical outcomes in 420 patients with psoriatic arthritis taking anti-tumor necrosis factor drugs in real-world settings 116
Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study 116
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 111
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 109
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 109
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis 108
A convolutional neural network with transfer learning for automatic discrimination between low and high-grade synovitis: a pilot study 107
Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art 106
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 106
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 106
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 105
Improvement of Refractory Dysphagia in Patients with Idiopathic Inflammatory Myopathies Receveing Immunoglobulin Intravenous Therapy 105
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 103
THU0168 Relationships between body fat composition assessed with bioelectrical impedance analysis, serum adipokines and disease activity in patients with rheumatoid arthritis 102
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study 101
Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification 100
Behçet's syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 100
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art 100
Pain Processing and Vegetative Dysfunction in Fibromyalgia: A Study by Sympathetic Skin Response and Laser Evoked Potentials 99
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 98
improvement of refractory dysphagia in patients with idiopathic inflammatory myopathies receveing immunoglubulin intravenous therapy 96
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings 96
The role of biosimilars in uveitis: Long-term real-world outcomes of the switch from original to biosimilar TNF-alpha inhibitors 96
SAT0380 FIBROMYALGIA IS THE STRONGEST NEGATIVE PREDICTOR FOR THE ACHIEVEMENT OF EITHER REMISSION AND MINIMAL DISEASE ACTIVITY IN NAIVE PSORIATIC ARTHRITIS PATIENTS STARTING BIOLOGIC DRUGS 95
IL-6 blockade in the management of non-infectious uveitis 93
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 91
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment 91
Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study 89
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 88
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey 87
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis 87
null 86
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: an observational multicentre study 86
Anakinra effectiveness in refractory polyserositis: An Italian multicenter study 84
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 84
A Machine Learning Approach to Predict Remission in Patients With Psoriatic Arthritis on Treatment With Secukinumab 83
Heterogeneous clinical spectrum of interstitial lung disease in patients with anti-EJ anti-synthetase syndrome: a case series 83
Biological therapies for the treatment of Behçet’s disease-related uveitis beyond TNF-alpha blockade: a narrative review 82
null 82
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis 82
null 81
null 80
Putative role of serum amyloid-A and proinflammatory cytokines as biomarkers for behcet's disease 80
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 80
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 79
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 79
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 78
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients 77
Complete Hydatidiform Mole Mimicking Sacroiliitis 77
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 75
null 75
null 72
null 72
Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitis 72
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 72
null 71
Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy 71
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis 71
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis 71
Totale 11.072
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.964
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021868 0 0 0 0 0 142 140 133 121 142 99 91
2021/2022985 73 40 20 42 40 82 67 53 72 81 120 295
2022/20231.547 219 199 128 123 114 241 34 198 207 12 51 21
2023/2024545 41 107 24 44 48 129 18 28 6 15 13 72
2024/20252.950 66 37 197 64 47 279 318 347 151 201 439 804
2025/20264.145 908 311 466 969 1.174 317 0 0 0 0 0 0
Totale 15.833